Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Estrongenic Steroid Hormones in Lung Cancer
Jill M. Siegfried
, Laura P. Stabile
Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
97
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Estrongenic Steroid Hormones in Lung Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung Cancer
100%
Estrogen Receptor
100%
Steroid Hormones
100%
Lung
60%
Estrogen
60%
Aromatase
40%
Lung Tissue
20%
Progesterone
20%
Progesterone Receptor
20%
Testosterone
20%
Inflammatory Cells
20%
Estrogen Receptor-positive
20%
Mid-1990s
20%
Pulmonary Inflammation
20%
Lung Development
20%
CYP19
20%
Human Lung Tumors
20%
Reproductive System
20%
Rate-limiting Enzyme
20%
Medicine and Dentistry
Lung Cancer
100%
Estrogen Receptor
100%
Steroid Hormone
100%
Lung
66%
Aromatase
33%
Lung Tumor
16%
Receptor
16%
Inflammatory Cell
16%
Cytochrome P450 Family 19
16%
Lung Development
16%
Reproductive System
16%
Progesterone
16%
Progesterone Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Lung Cancer
100%
Steroid Hormone
100%
Aromatase
33%
Lung Tumor
16%
Receptor
16%
Cytochrome P450 Family 19
16%
Progesterone
16%
Progesterone Receptor
16%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Enzyme
33%
Aromatase
33%
Lung Development
16%
Progesterone Receptor
16%
Progesterone
16%
Reproductive System
16%